Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Human Molecular Genetics|July 1, 2020
Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?Jennifer K Hockings, Jessica A Castrillon, Feixiong Cheng
Nutrition and Cancer|November 16, 2007
Cyclooxygenase-2 promoter activation by the aromatic hydrocarbon receptor in breast cancer mcf-7 cells: repressive effects of conjugated linoleic acidStephanie C Degner, Michael Q Kemp, Jennifer K Hockings, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2017
Impact of recommended weight-based dosing of granulocyte-colony stimulating factors in acute leukemia and stem cell transplant patientsJennifer K Hockings, Diwura K Owolabi, Joyce E Broyles, et al.
Breast Cancer Research : BCR|April 2, 2008
Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 geneJennifer K Hockings, Stephanie C Degner, Sherif S Morgan, et al.
Cleveland Clinic Journal of Medicine|February 5, 2020
Pharmacogenomics: An evolving clinical tool for precision medicineJennifer K Hockings, Amy L Pasternak, Angelika L Erwin, et al.
Cancer Research|February 21, 2006
The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogenJennifer K Hockings, Patricia A Thorne, Michael Q Kemp, et al.
Journal of the American Pharmacists Association : Japha|February 11, 2023
Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: Barriers and outcomesAlayna M Kehr, Gina Ayers, Saket Saxena, et al.
Journal of the American Pharmacists Association : Japha|January 29, 2026
Impact of pharmacist collaborative practice agreement on pharmacogenomic implementation for patients referred from geriatric medicineRachel C Larmer, Gina Elder, Alayna M Wagner, et al.
Parkinsonism & Related Disorders|November 17, 2024
Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic reviewHenry Mauricio Chaparro-Solano, Maria Rivera Paz, Saar Anis, et al.
Neoplasia (New York, N.Y.)|October 19, 2005
An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcriptionBrandon D Jeffy, Jennifer K Hockings, Michael Q Kemp, et al.
Pageof 1